BeiGene, Ltd. (BGNE): Price and Financial Metrics


BeiGene, Ltd. (BGNE)

Today's Latest Price: $203.31 USD

0.59 (-0.29%)

Updated Nov 20 4:00pm

Add BGNE to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 215 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

BGNE Stock Summary

  • BeiGene Ltd's stock had its IPO on February 3, 2016, making it an older stock than merely 12.13% of US equities in our set.
  • With a price/sales ratio of 26.6, BeiGene Ltd has a higher such ratio than 95.97% of stocks in our set.
  • In terms of twelve month growth in earnings before interest and taxes, BeiGene Ltd is reporting a growth rate of 175.23%; that's higher than 92.95% of US stocks.
  • Stocks that are quantitatively similar to BGNE, based on their financial statements, market capitalization, and price volatility, are AGIO, KALV, MCRB, WVE, and DCPH.
  • Visit BGNE's SEC page to see the company's official filings. To visit the company's web site, go to www.beigene.com.
BGNE Daily Price Range
BGNE 52-Week Price Range

BGNE Stock Price Chart More Charts


BGNE Price/Volume Stats

Current price $203.31
Prev. close $203.90
Day low $198.32
Day high $208.40
50-day MA $147.83
200-day MA $135.32
52-week high $208.40
52-week low $108.00
Volume 377,400
Avg. volume 331,776
Dividend yield N/A
Market Cap 9.65B

BeiGene, Ltd. (BGNE) Company Bio


BeiGene, Ltd., a clinical-stage biopharmaceutical company, discovers and develops various oncology drugs in the People’s Republic of China. The company was founded in 2010 and is based in the Cayman Islands.





BGNE Latest News Stream


Event/Time News Detail
Loading, please wait...

BGNE Latest Social Stream


Loading social stream, please wait...

View Full BGNE Social Stream

BGNE Price Returns

1-mo 52.86%
3-mo 41.25%
6-mo 60.58%
1-year 61.59%
3-year 535.34%
5-year N/A
YTD 44.95%
2018 43.53%
2017 221.87%
2016 N/A
2015 N/A
2014 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.5159 seconds.